Intralesional epidermal growth factor for diabetic foot wounds: the first cases in Turkey.
CONCLUSION: Thus, this preliminary study suggests that EGF seems to be a potential adjunctive treatment option in patients with limb-threatening diabetic foot wounds.
PMID: 26268583 [PubMed]
Source: Diabetic Foot and Ankle - Category: Endocrinology Tags: Diabet Foot Ankle Source Type: research
More News: Biotechnology | Diabetes | Diabetic Ulcers | Endocrinology | Genetics | Middle East Health | Study